Clinical Trial Update: Randomized Double Blind Cross Over Study for Nabilone in Spasticity in Spinal Cord Injury Persons [Phase 2]

View source ↗

Summary

Phase 2 randomized, double-blind, cross-over trial evaluating nabilone for spasticity in people with spinal cord injury was completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spasticity
• Spinal Cord Injury

Drugs mentioned

• Nabilone (nabilone)

Snippet

Sponsor: University of Manitoba | Conditions: Spasticity in Spinal Cord Injured Persons | Phase 2 | Status: COMPLETED